Mantle cell lymphoma: open trials in Romania

• NCT06980116

  Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

  Trial Treatment · Phase 1 · Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

  Arensia Clinics S.R.L., Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca

  Registry updated 2026-08-13

• NCT05544019

  Study of SGR-1505 in Mature B-Cell Neoplasms

  Trial Treatment · Phase 1 · Schrödinger, Inc.

  Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca

  Registry updated 2026-02-13

• NCT06363994

  A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL

  Trial Treatment · Phase 3 · InnoCare Pharma Inc.

  Memorial Healthcare International S R L, Bucharest · Institutul Clinic Fundeni, Bucharest · Spitalul Clinic Colțea, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Spitalul Clinic Municipal Filantropia Craiova, Craiova · Institutul Regional de Oncologie Iasi, Iași

  Registry updated 2024-12-27

All Mantle cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error